RIGL
Rigel Pharmaceuticals Inc
Price:  
13.32 
USD
Volume:  
74,932.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RIGL Fair Value

-130.37 %
Upside

As of 2024-09-08, the Fair Value of Rigel Pharmaceuticals Inc (RIGL) is -4.04 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 13.32 USD, the upside of Rigel Pharmaceuticals Inc is -130.37%.

Note: valuation result may not be accurate due to the company's negative EPS.

13.32 USD
Stock Price
-4.04 USD
Fair Price
FAIR VALUE CALCULATION

RIGL Fair Value

Peter Lynch's formula is:

RIGL Fair Value
= Earnings Growth Rate x TTM EPS
RIGL Fair Value
= 5.00 x -0.81
RIGL Fair Value
= -4.04

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31 5Y Avg
Net income -66.90 -29.70 -17.90 -58.60 -25.09 -39.64
YoY growth 5.11% 55.61% 39.73% -227.37% 57.18% -13.95%

RIGL Fair Value - Key Data

Market Cap (mil) 234.30
P/E
Forward P/E
EPS -0.81
Avg earnings growth rate -13.95%
TTM earnings -14.23